Patents
Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
04/2004
04/20/2004US6723749 Treating bacterial infections
04/20/2004US6723731 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
04/15/2004WO2004031141A2 Process for preparing fluorocarboxylic acids
04/15/2004WO2004014835A3 Resolvins: biotemplates for therapeutic interventions
04/15/2004US20040073057 Heating with thionyl chloride; racemization
04/15/2004US20040072820 Naphthyl compounds, intermediates, compositions, and methods of use
04/14/2004EP1406854A1 Process and intermediates to prepare latanoprost
04/13/2004US6720354 Prevention of neutrophil recruitment
04/13/2004CA2365298C Quaternary ammonium and waterproofing/preservative compositions
04/08/2004WO2004029008A2 Process for preparing fluorocarboxylic acids
04/08/2004WO2004006883A8 Skin care cosmetic compositions containing carboxyalkylates of branched alcohols and/or alkoxylates thereof
04/08/2004WO2003101392A3 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
04/08/2004US20040068140 Preparation of mandelic acid derivatives
04/08/2004US20040067202 Novel alkanoic acid derivaties
04/08/2004DE10217208A1 Verfahren zur Herstellung von Ethercarbonsäuren mit niedrigem Stockpunkt Process for the preparation of ether carboxylic acids with low pour point
04/07/2004EP1404638A1 Synthesis of 4-phenylbutyric acid
04/07/2004EP1089970B1 Oxidation inhibitors for prostane derivatives
04/07/2004EP0910561B1 Inhibitors of oleamide hydrolase
04/07/2004CN1487919A New mandelic acid derivatives and their use as throbin inhibitors
04/07/2004CN1486969A Composite mineral salf of potassium-magnesium hydrogen citrate and its prepn process
04/06/2004US6716832 Arylphenyl-substituted cyclic ketoenols
04/06/2004CA2365054C Quaternary ammonium and waterproofing/preservative compositions
04/06/2004CA2121060C Preparation of lignan analogues
04/01/2004WO2004027118A1 Method for preparing a polycarboxylic composition comprising an electrochemical oxidation stage of a monosaccharide composition
04/01/2004WO2003088927A3 Novel curcumin analogues and uses thereof
04/01/2004US20040063994 Catalytic hydrogenation, reduction of oxyaminoacids; hydrolysis; by-product inhibition
04/01/2004US20040063932 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation
04/01/2004US20040063781 Compounds active at the glucocorticoid receptor II
04/01/2004US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability
03/2004
03/31/2004EP1401815A1 Process for the preparation of a highly pure pharmaceutical intermediate, 4-(cyclopropylcarbonyl)-alpha,alpha-dimethylphenyl acetic acid
03/31/2004EP1185498B1 Synthesis of optically active cyclohexylphenylglycolic acid and its esters
03/31/2004EP0770065B1 Tri-substituted phenyl derivates useful as pde iv inhibitors
03/31/2004CN1485310A Process for preparing high-purity 2-methyl-4-chloro phenoxyacetic acid
03/30/2004US6713647 Compounds having activity as inhibitors of cytochrome P450RAI
03/30/2004US6713512 Antioxidant; cellular proliferation inhibition
03/30/2004US6713507 Ether compounds and compositions for cholesterol management and related uses
03/30/2004US6713503 1-(2,4-dimethyl-phenyl)-2,4-dihydroxy-3-(4-methyl-benzoyl)-5-oxo-2,5 -dihydro-1h-pyrrole-2-carboxylic acid methyl ester
03/25/2004WO2004024676A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
03/25/2004US20040059144 Aspirin-triggered lipid mediators
03/25/2004US20040058988 Fatty acid synthase inhibitors
03/25/2004CA2498045A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
03/24/2004EP1399402A1 Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives
03/24/2004EP1399138A1 Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate
03/24/2004CN1484631A Preparation of enantiomerically pure hydroxy esters and acids
03/23/2004US6710206 Poly(3-cyclopropyl-3-hydroxypropionate) and processes for its preparation and derivatives thereof
03/18/2004WO2004022552A1 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
03/18/2004US20040053401 Preparation of enantiomerically pure hydroxy esters and acids
03/17/2004EP1397335A1 Resolution process for (r)-(-)-2-hydroxy-2-(2-chlorophenyl)acetic acid
03/16/2004US6706917 Decyclization and deesterification of 5,6-dihydro-2(4h)-benzofuranone in presence of organic acid metal salt catalyst
03/11/2004WO2003099759A8 Preparation and application of transhintotalphenolic acid
03/11/2004US20040049076 From 1,1,1-trifluoro-3,3-dihaloacetone; acid may be esterified and ester product reduced to form 3,3,3-trifluoro-1,2-propylene glycol
03/11/2004US20040049072 RXR modulators with improved pharmacologic profile
03/10/2004CN1480444A Method for producing dehydraed yoghurt
03/10/2004CN1141416C Indium source reagent compsns.
03/10/2004CN1141288C Reaction extraction process of refining glyoxalic acid
03/09/2004US6703426 Treatment of breast cancer
03/04/2004US20040044258 Substituted phenylalkanoic acid derivatives and use thereof
03/04/2004US20040044050 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents
03/04/2004US20040042981 Glycosyltransferase inhibitor; bactericide
03/03/2004EP1394147A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
03/03/2004EP1394141A1 Preparation of aryl olefins
03/03/2004EP1392637A2 Modulators of peroxisome proliferator activated receptors
03/03/2004EP1392636A1 Process for preparing carboxylic acids and derivatives thereof
03/03/2004CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
03/03/2004CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes
03/03/2004CN1479712A Ketone compounds and compositions for cholesterol management and related uses
03/03/2004CN1140508C Substed 4-biphenyl-4-hydroxybutyric acid derivs, and matrix metalloprotease inhibitors
03/03/2004CN1140346C Process for preparing carboxylic acid salts and catalyst useful in such process
03/02/2004US6700025 Process for stereoselective synthesis of prostacyclin derivatives
03/02/2004US6699910 Ketone compounds and compositions for cholesterol management and related uses
03/02/2004US6699905 Comprising administering to the subject an effective anti-inflammatory amount of a pharmaceutical composition comprising a lipoxin a4 compound and a pharmaceutically acceptable carrier
02/2004
02/25/2004EP1391199A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
02/25/2004EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
02/25/2004EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's)
02/25/2004EP1087924B1 Method for preparing p-hydroxymandelic compounds optionally substituted
02/25/2004EP0873301B1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity
02/25/2004CN1139570C Inhibition of matrix metalloproteases by acetylene-containing compound
02/25/2004CN1139375C Oxa diacids and related compounds for treating skin disease
02/19/2004WO2004014835A2 Resolvins: biotemplates for therapeutic interventions
02/19/2004WO2002030356A3 Synthesis of epothilones and relates analogs
02/19/2004US20040034243 Oxidation of monomethylolalkanal or polymethylolalkanal to produce monomethylolalkanoic acid or polymethylolalkanoic acid using hydrogen peroxide
02/19/2004US20040034097 Pesticidal activity of functionalized alkenes
02/18/2004CN1138735C Process and intermediate compounds for preparation of pesticidal fluoroolefin compounds
02/17/2004US6693215 Process for the preparation of salts of L-carnitine and alkanoyl L-carnitine with mucic acid
02/12/2004WO2004013069A1 A process for the optical resolution of a precursor of sclareolide
02/12/2004WO2003087824A3 Charge-balanced chemoselective linkers
02/12/2004US20040030054 Quaternary ammonium, phosphonium compound
02/12/2004US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
02/12/2004US20040029839 Compositions comprising jasmonic acid derivatives and use of these derivatives
02/12/2004DE10057415B4 Verfahren zur Herstellung von Chinon-Derivaten und deren Verwendung Process for the preparation of quinone derivatives and the use thereof
02/11/2004EP1388555A2 A proces for the preparation of perfluoropolyethers acyl-fluoride ended by reduction of the corresponding peroxidic perfluoropolyethers
02/11/2004EP1388554A2 Hydrofluoroethers having at least one hydrogenated -OCFX'CH3 end group wherein X'=F, CF3 and their preparation process
02/11/2004EP1387825A1 Thyroid hormone receptor antagonists for cardiac & metabolic disorders ii
02/11/2004EP0859608B1 Treating niddm with rxr agonists
02/11/2004CN1474799A Method for pruification of alpha-hydroxy acid on industrial scale
02/11/2004CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
02/10/2004US6689902 Reductive alkylation
02/10/2004US6689901 Process and intermediates to prepare latanoprost
02/10/2004CA2164951C Lipoxin compounds
02/10/2004CA2124744C Process for the stereospecific synthesis of leukotriene b4 under its 6z, 8e and 10e, and intermediate products thereof
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 147